INFbeta therapy for COVID-19 [electronic resource] : the new SNG001 drug / Stephen Holgate.
Material type:
Audio interview.
Title from title frames.
Contents: Why INFβ was chosen as a therapy for COVID-19 -- Previous use of INFβ by inhalation -- Safety of INFβ as a therapy -- SNG001 mode of delivery -- SNG001 clinical trials and future prospects.
Access restricted to subscribers.
Mode of access: World Wide Web.